Inhaler

When patients with asthma or chronic obstructive pulmonary disease switch their inhaler regimen, there can be consequences for clinical outcomes, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.

Rates of overprescribing of short-acting beta agonist asthma inhalers remain high and vary significantly among practices, according to new data published in the British Journal of General Practice.

Patients with COPD who initiated of single-inhaler triple therapy had improved inhaler adherence and persistence compared with multiple-inhaler triple therapy users, according to a real-world study.

Patients with asthma who switched from a metered-dose inhaler to a dry-powder inhaler cut their inhaler carbon footprint by more than half, without loss of asthma control, according to data published in Thorax.

In a new study, novel metrics showed that lower time adherence to asthma controller medications was associated with greater risk for decline in asthma symptom control.

Among new initiators of multiple-inhaler triple therapy for asthma, discontinuation was high, although approximately one-third of patients reinitiated their therapy, researchers reported at the CHEST Annual Meeting.

A pharmacist-led intervention may aid in improving inhaler techniques for patients with asthma and COPD and may have a positive impact on health care resource use, according to results of a pilot study published in Respiratory Medicine.

BreatheSuite announced that it received 510(k) clearance from the FDA for its Metered-Dose Inhaler V1 device, which turns existing inhalers into smart inhalers for people with asthma and COPD, according to a company press release.

In a new study, a high proportion of patients with COPD used their pressurized metered dose inhalers incorrectly, but inhaler techniques improved with short trainings in the clinic, researchers reported in BMC Pulmonary Medicine.

An automatic electronic computer alert for general practitioners helped identify and reduce excessive prescribing of short-acting beta agonists for patients with asthma.